February 21, 2020 Athos Therapeutics CEO, Dr. Dimitrios Iliopoulos, participates in the UCLA Anderson School of Management Healthcare Conference (VITALS 2020 Conference)
March 18, 2020 Opinion: Dr. Claudio Fiocchi “The need for AI-based precision therapy in inflammatory bowel disease”
February 20, 2019 Article: Environmental triggers in IBD: a review of progress and evidence, Nature Reviews Gastroenterology & Hepatology
